Immunizations

References

Citations

1. Parker SK, et al. (2004). Thimerosal-containing vaccines and autistic spectrum disorder: A critical review of published original data. Pediatrics 114(3): 793–804.

2. U.S. Food and Drug Administration (2006). Thimerosal content in some currently manufactured U.S. licensed vaccines. Available online: http://www.fda.gov/cber/vaccine/thimerosal.htm#t3.

3. Demicheli V, et al. (2007). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

4. Centers for Disease Control and Prevention (2008). Recommended immunization schedules for persons aged 0–18 years—United States, 2008. MMWR, 57(01): Q1–Q4. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a8.htm. [Erratum in MMWR, 57(12): 319. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5712a6.htm.]

5. Centers for Disease Control and Prevention (2005). Notice to readers: Licensure of a combined live attenuated measles, mumps, rubella, and varicella vaccine. MMWR, 54(47): 1212–1214. Also available online: http://www.cdc.gov/mmwr/PDF/wk/mm5447.pdf. [Erratum in MMWR, 54(48): 1237. Also available online: http://www.cdc.gov/mmwr/pdf/wk/mm5448.pdf.]

6. Centers for Disease Control and Prevention (2007). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR-6): 1–60. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5606.pdf.

7. Atkinson W, et al., eds. (2007). Epidemiology and Prevention of Vaccine-Preventable Diseases, updated 10th ed. (The Pink Book). Washington, DC: Public Health Foundation. Also available online: http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm.

8. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR–2): 1–24. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5602.pdf.

9. Saslow D, et al. (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians, 57(1): 7–28.

10. Centers for Disease Control and Prevention (1998, updated 2007). Guidelines for Vaccinating Pregnant Women From Recommendations of the Advisory Committee on Immunization Practices (ACIP). Available online: http://www.cdc.gov/vaccines/pubs/preg-guide.htm.

11. U.S. Food and Drug Administration (2007). FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01611.html.

12. Mitka M (2007). Bioterror vaccine production: Take 2. JAMA, 297(6): 575–576.

13. Breman JG, Henderson DA (2002). Diagnosis and management of smallpox. New England Journal of Medicine, 346(17): 1300–1308.

14. Centers for Disease Control and Prevention (2006). Smallpox fact sheet: Vaccine overview. Available online: http://www.bt.cdc.gov/agent/smallpox/vaccination/facts.asp.

Other Works Consulted

• Centers for Disease Control and Prevention (2007). Mercury and vaccines (Thimerosal). Available online: http://www.cdc.gov/vaccinesafety/concerns/thimerosal.htm.

• American Academy of Pediatrics (2007). Hepatitis A vaccine recommendations. Pediatrics, 120(1): 189–199. Also available online: http://aappolicy.aappublications.org/cgi/reprint/pediatrics;120/1/189.pdf.

• Centers for Disease Control and Prevention (1998). Measles, mumps, and rubella—Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 47(RR-8): 1–59. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr4708.pdf.

• Centers for Disease Control and Prevention (2005). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of infants, children, and adolescents. MMWR, 54(RR-16): 1–23. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm. [Erratum in MMWR, 55(06): 158–159. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5506a6.htm.]

• Centers for Disease Control and Prevention (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. MMWR, 55(RR-16): 1–33. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm. [Erratum in MMWR, 56(42): 1114.]

• Centers for Disease Control and Prevention (2006). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55 (RR-7): 1–23. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5507.pdf.

• Centers for Disease Control and Prevention (2006). Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-3): 1–44. Also available online: http://www.cdc.gov/mmwr/PDF/RR/RR5503.pdf.

• Centers for Disease Control and Prevention (2006). Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee, for Use of Tdap Among Health-Care Personnel. MMWR, 55(RR-17): 1–37. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5517.pdf.

• Centers for Disease Control and Prevention (2007). Notice to readers: Expansion of use of live attenuated influenza vaccine (FluMist®) to children aged 2–4 years and other FluMist changes for the 2007–08 influenza season. MMWR, 56(46): 1217–1219. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a4.htm?s_cid=mm5646a4_e.

• Centers for Disease Control and Prevention (2007). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 56(RR-4): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5604.pdf.

• Centers for Disease Control and Prevention (2007). Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR, 56(31): 794–795. Also available online: http://www.cdc.gov/mmwr/PDF/wk/mm5631.pdf.

• Centers for Disease Control and Prevention (2008). Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 57(Early Release): 1–30. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr57e0515.pdf.

• Centers for Disease Control and Prevention (2008). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 57: 1–51. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr57e0514.pdf.

• Centers for Disease Control and Prevention (2008). Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24–59 months who are not completely vaccinated. MMWR, 57(13): 343–344. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5713a4.htm?s_cid=mm5713a4_e.

• Centers for Disease Control and Prevention (1997). Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 46(RR-8): 1–25.

• Committee on Infectious Disease, American Academy of Pediatrics (1999). Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics, 104(6): 1404–1406.

• Committee on Infectious Diseases, American Academy of Pediatrics (2000). Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics, 106(2): 362–366.

• Dear KB G, et al. (2007). Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Systematic Reviews (2).

• Orenstein WA, Pickering LK (2007). Immunization practices. In RM Kliegman et al., eds., Nelson Textbook of Pediatrics, 18th ed., pp. 1058–1070. Philadelphia: Saunders Elsevier.

• Pneumococcal vaccine (Prevnar) for otitis media (2003). Medical Letter on Drugs and Therapeutics, 45 (W1153B): 27–28.

• Thompson WW, et al. (2007). Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. New England Journal of Medicine, 357(13): 1281–1292.

• U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2006). General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-15): 1–48. Also available online: http://www.cdc.gov/mmwr/PDF/rr/rr5515.pdf. [Erratum in MMWR, 56(11): 256. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5611a6.htm?s_cid=mm5611a6_e.]

• Weller PF (2005). Health advice for international travelers. In DC Dale, DD Federman, eds., ACP Medicine, Clinical Essentials, chap. 7. New York: WebMD.

Go to previous section	Go to top of page	Go to next section
Author:	Debby Golonka, MPH	Last Updated: May 29, 2008
Medical Review:	Michael J. Sexton, MD - Pediatrics
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.